Biotechnology
| Fri 26 Jun 2026
Munich, June 26 -- Edigene Biotechnology Inc has sought patent for Engineered T Cell Having Prolonged in Vivo Half-life and Preparation Method Therefor. This invention was developed by Zhang Yunyi, Lu Zhiwei, Liang Feifei, Zhang Haixia, Yang Zhonghan, Yi Yuting, Wu Lanlan, Fu Jianqiang, Yuan Pengfei and Sun Yu.
The patent app..